 associ antiphospholipid antibodi cardiac abnorm patient system lupu erythematosu purpos antiphospholipid antibodi thrombosi recurr abort thrombocytopenia patient system lupu erythematosu sle relationship cardiac diseas clear purpos studi associ anti-phospholipid antibodi cardiac abnorm patient sle patient method total consecut sle patient healthi sex- age-match control subject case-control studi particip underw m-mode two-dimension doppler echocardiographi antiphospholipid antibodi level patient preval antiphospholipid antibodi patient echocardiograph abnorm result control group sle patient pericardi abnorm ventricular hypertrophi atrial enlarg ventricular dysfunct verruc valvular thicken global valvular dysfunct mitral aortic regurgit abnorm antiphospholipid antibodi isol ventricular global segment dysfunct posit verruc valvular mitral aortic thicken posit global valvular mitral aortic thicken dysfunct posit mitral regurgit posit aortic regurgit posit conclus valvular lesion myocardi dysfunct elev antiphospholipid antibodi studi import implic pathogen role anti-phospholipid antibodi relat cardiac abnorm